Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-041957

Director acquired 5,590 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Kazam Joshua A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-07-10 Other acquisition : show line 1 in the form +5,590 1,412,618 D
Loading xslF345X03/doc4.xml…